8-K: SS&C Technologies Reports Strong Q1 2024 Results with Revenue and EPS Growth

SS&C Technologies announced a strong first quarter for 2024, with both GAAP and adjusted revenue up 5.3% and adjusted diluted earnings per share up 12.3%.

Summary

• SS&C Technologies reported its financial results for the first quarter of 2024, showing a 5.3% increase in both GAAP and adjusted revenue, reaching $1,435.0 million and $1,435.8 million respectively.
• GAAP diluted earnings per share increased by 26.5% to $0.62, while adjusted diluted earnings per share rose by 12.3% to $1.28.
• The company's GAAP net income attributable to SS&C was $157.6 million, a 25.1% increase, and adjusted consolidated EBITDA was $556.8 million, up 9.4%.
• SS&C repurchased 0.8 million shares for $52.9 million at an average price of $63.24 per share and paid down $79.9 million in debt, reducing the net leverage ratio to 2.95 times consolidated EBITDA.
• Operating cash flow decreased by 29.2% to $180.5 million compared to $254.8 million in the same period last year.
• The company ended the quarter with $412.5 million in cash and cash equivalents and $6,679.0 million in gross debt.
• SS&C is guiding for Q2 2024 adjusted revenue between $1,412.1 million and $1,452.1 million and full year adjusted revenue between $5,694.6 million and $5,854.6 million.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue and earnings growth, debt reduction, and share buybacks. The decrease in operating cash flow and the healthcare segment's decline are minor concerns, but overall the sentiment is positive.

Positives

• SS&C achieved record adjusted revenue of $1,435.8 million in Q1 2024.
• The company experienced strong growth in both GAAP and adjusted earnings per share.
• SS&C successfully reduced its debt by $79.9 million in Q1 2024.
• The company's share buyback program returned capital to shareholders.
• SS&C's organic growth rate was a solid 4.7%.
• Intralinks showed exceptional organic growth of 23.0%.

Negatives

• Operating cash flow decreased by 29.2% to $180.5 million compared to the same period last year.
• Healthcare segment experienced an 8.5% decline in organic growth due to attrition carried over from 2023.

Risks

• The company's forward-looking statements are subject to various risks and uncertainties, including economic conditions, the financial services industry, and the ability to realize benefits from acquisitions.
• There are risks associated with customer consolidation, the variability of revenue due to securities market activity, and the ability to retain and attract clients.
• SS&C faces competition, litigation risks, and potential disruptions to its software-enabled services.
• The company is exposed to risks related to foreign operations, privacy concerns, and evolving regulations.
• There are risks associated with the company's substantial indebtedness.

Future Outlook

SS&C is guiding for Q2 2024 adjusted revenue between $1,412.1 million and $1,452.1 million and full year adjusted revenue between $5,694.6 million and $5,854.6 million. They are also guiding for full year adjusted diluted EPS between $4.93 and $5.17.

Management Comments

• SS&C started off the year strong, with record adjusted revenues, and organic growth coming in at 4.7 percent, said Bill Stone, Chairman and Chief Executive Officer.
• We were able to capitalize on stronger market conditions, and our growth was driven by Intralinks and Alternatives.
• We continue to deploy intelligent automation and generative AI throughout SS&C, and we are seeing real benefits in client service and productivity.

Industry Context

SS&C's results reflect a positive trend in the financial technology sector, with increased demand for software and software-enabled services. The company's focus on automation and AI aligns with industry trends towards digital transformation and efficiency gains.

Comparison to Industry Standards

• SS&C's 5.3% revenue growth is solid, but needs to be compared to peers like Fiserv (FISV) and Fidelity National Information Services (FIS), which also provide financial technology solutions.
• SS&C's adjusted EPS growth of 12.3% is strong, but needs to be benchmarked against the growth rates of similar companies in the software and financial services sectors.
• The company's debt reduction and share buyback program are positive signs, but the net leverage ratio of 2.95x should be compared to industry averages to assess its financial health.
• The 4.7% organic growth rate is a good indicator of underlying business strength, but needs to be compared to the organic growth rates of competitors in the financial technology space.
• Intralinks' 23% organic growth is exceptional and suggests a strong market position in its niche, but this needs to be compared to the growth of other data and collaboration platforms.

Stakeholder Impact

• Shareholders will benefit from the increased earnings per share and share buyback program.
• Employees may see increased job security and opportunities due to the company's growth.
• Customers will benefit from the company's continued investment in technology and client service.
• Creditors will be reassured by the company's debt reduction efforts.

Next Steps

• SS&C will continue to focus on deploying intelligent automation and generative AI.
• The company will host an earnings call to discuss the Q1 2024 results.
• SS&C will continue to execute its capital allocation strategy, including debt reduction and share repurchases.

Key Dates

Keywords

financial software, investment management, healthcare software, SaaS, EBITDA, revenue, earnings per share, debt reduction, share buyback, organic growth